Colorectal Cancer: a Risk-adapted Screening and the Role of the Physician in the Prevention of This Cancer
From: Service d’oncologie, Service de génétique médicale, HUG, 1211 Genève 14. pierre.chappuis@hcuge.ch
Revue médicale suisse
- Publish Date: May 2006
- ISSN: 1660-9379
- Volume: 2
- Issue: 66
- Pages: 1314, 1316, 1318-23
- Medium: Print
- Language:
- Citation (JAMA): Chappuis P O, Hutter P, et al. Colorectal Cancer: a Risk-adapted Screening and the Role of the Physician in the Prevention of This Cancer. May 2006;2:1314, 1316, 1318-23
Abstract
The benefit of colorectal cancer screening in the average-risk population, as well as in the presence of high risk genetic predispositions, has been validated by a significant reduction of the mortality associated with the disease. Several screening options are recognized and compliance with these measures remains a public health problem. The physician plays a key role in the promotion of the colorectal cancer screening. Collecting a precise family history is crucial for the identification of individuals at high risk. Validated clinical criteria are helpful for the identification of individuals with a genetic predisposition to colorectal cancer. Molecular screening for the main colorectal cancer predisposing genes should now be integrated in the clinical management of these patients and their families.
Mesh Headings (Keywords): Colorectal Neoplasms, Humans, Mass Screening, Physician’s Role, Risk Factors
Check for Full Text / PubMed Unique Identifier (PMID): 16775992
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.